IL10 and neoplasm: IL-10, one of the Th2 cytokines, downregulates tumour specific immune responses by directly suppressing IFNc and IL-12 production, thereby reducing major histocompatibility complex expression on the surface of tumour cells and inhibited tumour antigen presentation by antigen presenting cells.27–29